Catheter-Based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure
Clinical experience with Six-Month Follow-Up
Pieter C. Smits, MD, PhD*,*,
Robert-Jan M. van Geuns, MD, PhD ,
Don Poldermans, MD, PhD*,
Manolis Bountioukos, MD*,
Emile E. M. Onderwater*,
Chi Hang Lee, MD*,
Alex P. W. M. Maat, MD* and
Patrick W. Serruys, MD, PhD*
* Department of Cardiology, Thorax Center, Rotterdam, The Netherlands
Department of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands
View larger version (70K):
[in a new window]
|
Figure 1 NOGA maps (left = unipolar voltage maps; right = linear local shortening maps) in the right anterior oblique (top) and anteroposterior (bottom) views of Patient no. 2 after 19 injections with autologous skeletal myoblasts in the anteroseptal and anterior myocardial scar and border zone. The myocardial scar is indicated in red on the unipolar voltage map (<6 mV) and on the local linear shortening map (<2%). The black dots indicate the transendocardial injection sites.
|
|
View larger version (17K):
[in a new window]
|
Figure 2 Changes in regional wall thickening for all 304 magnetic resonance imaging segments. The open and solid bars indicate the number of segments with wall thickening at baseline and three-month follow-up (FU), respectively. Compared with baseline, less segments showed thinning and more segments showed moderate thickening at three-month follow-up, and less segments with greater wall thickening were observed at that point.
|
|
View larger version (22K):
[in a new window]
|
Figure 3 Cumulative distribution of regional wall thickening segments by magnetic resonance imaging at baseline (open circles) and three-month follow-up (x). At follow-up, there was a descriptive shift toward less thinning and moderate thickening in the target regions and less thickening in the normokinetic and hyperkinetic remote areas, indicating a kind of left ventricular remodeling.
|
|
|
